Nineteen genes (44%) demonstrated loss or promoter silencing of the wildtype allele in at least one tumour, with six genes (SLC12A4, LOXL2, ZCCHC4, LLGL2, MIPOL1, SCYL3) demonstrating this in multiple samples (Fig. 1). Here, LLGL2 is linked to neoplasm.